Tumor markers as a diagnostic key for hilar Cholangiocarcinoma
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 15 (8) , 357-61
Abstract
Hilar cholangiocarcinoma is the fourth most common gastrointestinal malignancy. CA19-9 and CEA are helpful devices in the management of gastrointestinal malignancies and belong to clinical routine in surgical oncology. But the validity of these parameters in terms of tumor extension and prognosis of bile duct malignancies still remains unclear. From 1998 to 2008, we obtained preoperative CA19-9 and CEA serum levels in 136 patients with hilar cholangiocarcinoma. We correlated tumor stage, resectability rate and survival with preoperative CA 19-9 and CEA serum levels. CA19-9 (UICC I: 253 ± 561U/ml; UICC II: 742 ± 1572 U/ml; UICC III: 906 ± 1708 U/ml; UICC IV: 1707 ± 3053U/ml) and CEA levels (UICC I: 2.9 ± 3.8U/ml; UICC II: 4.6 ± 6.5 U/ml; UICC III: 18.1 ± 29.6 U/ml; UICC IV: 22.7 ± 53.9 U/ml) increase significantly with rising tumor stage. Patients with pre?operative serum levels of CA19-9 (>1000U/ml) and CEA (>14.4ng/ml) showed a significant poorer resectability rate and survival than patients with lower CA19-9 and CEA serum levels respectively. CA19-9 and CEA serum levels are associated with the tumor stage. If preoperatively obtained CA19-9 and CEA serum levels are highly elevated patients have an even worse survival and the frequency of irresectability is significantly higher.Keywords
This publication has 28 references indexed in Scilit:
- Hilar Cholangiocarcinoma: Current ManagementAnnals of Surgery, 2009
- Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.2009
- Autoimmune pancreatitis: medical and surgical management.2007
- Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19-9European Journal of Gastroenterology & Hepatology, 2007
- Markedly Elevated Serum CA 19-9 Levels in Association With a Benign Biliary Stricture Due to Primary Sclerosing CholangitisJournal of Clinical Gastroenterology, 2007
- Treatment of nonresectable proximal bile duct carcinoma using intraoperative radiotherapy combined with hepatojejunostomyJournal of Surgical Oncology, 2002
- Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience.2001
- Early detection and treatment of cholangiocarcinomaLiver Transplantation, 2000
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.1975